Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Amortizatization of Intangibles (2022 - 2024)

Historic Amortizatization of Intangibles for Oncology Institute (TOI) over the last 3 years, with Q4 2024 value amounting to $1000.0.

  • Oncology Institute's Amortizatization of Intangibles fell 9994.79% to $1000.0 in Q4 2024 from the same period last year, while for Sep 2025 it was $1000.0, marking a year-over-year decrease of 9995.86%. This contributed to the annual value of $500000.0 for FY2024, which is 8099.58% down from last year.
  • Oncology Institute's Amortizatization of Intangibles amounted to $1000.0 in Q4 2024, which was down 9994.79% from $48000.0 recorded in Q3 2024.
  • In the past 5 years, Oncology Institute's Amortizatization of Intangibles ranged from a high of $1.9 million in Q4 2023 and a low of -$877000.0 during Q3 2023
  • Over the past 3 years, Oncology Institute's median Amortizatization of Intangibles value was $225500.0 (recorded in 2024), while the average stood at $415100.0.
  • Its Amortizatization of Intangibles has fluctuated over the past 5 years, first crashed by 312413.79% in 2023, then skyrocketed by 10547.32% in 2024.
  • Oncology Institute's Amortizatization of Intangibles (Quarter) stood at $991000.0 in 2022, then surged by 93.64% to $1.9 million in 2023, then crashed by 99.95% to $1000.0 in 2024.
  • Its Amortizatization of Intangibles stands at $1000.0 for Q4 2024, versus $48000.0 for Q3 2024 and $127000.0 for Q2 2024.